LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Co-Diagnostics Inc

Closed

SectorHealthcare

0.27 -15.62

Overview

Share price change

24h

Current

Min

0.27

Max

0.32

Key metrics

By Trading Economics

Income

-197K

-7.7M

Sales

113K

163K

Profit margin

-4,745.023

Employees

132

EBITDA

-526K

-7.8M

Dividends

By Dow Jones

Next Earnings

6 lis 2025

Market Stats

By TradingEconomics

Market Cap

4.2M

13M

Previous open

15.89

Previous close

0.27

News Sentiment

By Acuity

39%

61%

130 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Co-Diagnostics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 wrz 2025, 23:07 UTC

Acquisitions, Mergers, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 wrz 2025, 22:10 UTC

Major Market Movers

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 wrz 2025, 21:47 UTC

Earnings

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 wrz 2025, 16:52 UTC

Major Market Movers

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 wrz 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 wrz 2025, 21:40 UTC

Acquisitions, Mergers, Takeovers

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 wrz 2025, 21:07 UTC

Earnings

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 wrz 2025, 21:07 UTC

Earnings

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Rev $17.35B >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q EPS 82c >ATD.T

2 wrz 2025, 21:05 UTC

Earnings

Couche-Tard 1Q Net $782.5M >ATD.T

2 wrz 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2 wrz 2025, 20:53 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 wrz 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 wrz 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 wrz 2025, 20:27 UTC

Earnings

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 wrz 2025, 20:24 UTC

Acquisitions, Mergers, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 wrz 2025, 20:18 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 wrz 2025, 20:17 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 wrz 2025, 20:16 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 wrz 2025, 20:16 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 wrz 2025, 20:15 UTC

Acquisitions, Mergers, Takeovers

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 wrz 2025, 19:55 UTC

Earnings

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 wrz 2025, 19:50 UTC

Acquisitions, Mergers, Takeovers

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 wrz 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 wrz 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 wrz 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2 wrz 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 wrz 2025, 16:57 UTC

Acquisitions, Mergers, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer Comparison

Price change

Co-Diagnostics Inc Forecast

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

0.3495 / 0.3699Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

No Evidence

Sentiment

By Acuity

130 / 371 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.